Annuncio pubblicitario
Italia markets close in 12 minutes

  • FTSE MIB

    33.913,42
    +31,92 (+0,09%)
     

  • Dow Jones

    37.948,69
    +173,31 (+0,46%)
     

  • Nasdaq

    15.454,62
    -146,88 (-0,94%)
     

  • Nikkei 225

    37.068,35
    -1.011,35 (-2,66%)
     

  • Petrolio

    83,28
    +0,55 (+0,66%)
     

  • Bitcoin EUR

    60.475,94
    +538,55 (+0,90%)
     

  • CMC Crypto 200

    1.373,28
    +60,65 (+4,85%)
     

  • Oro

    2.409,00
    +11,00 (+0,46%)
     

  • EUR/USD

    1,0671
    +0,0025 (+0,23%)
     

  • S&P 500

    4.997,77
    -13,35 (-0,27%)
     

  • HANG SENG

    16.224,14
    -161,73 (-0,99%)
     

  • Euro Stoxx 50

    4.919,00
    -17,57 (-0,36%)
     

  • EUR/GBP

    0,8591
    +0,0036 (+0,41%)
     

  • EUR/CHF

    0,9696
    -0,0015 (-0,15%)
     

  • EUR/CAD

    1,4648
    -0,0002 (-0,02%)
     

Stereotaxis to Report First Quarter 2023 Financial Results on May 9, 2023

Stereotaxis, Inc.
Aggiornato ·2 minuto per la lettura
Stereotaxis, Inc.
Stereotaxis, Inc.

ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 first quarter on Tuesday, May 9, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

What:

 

Stereotaxis first quarter 2023 financial results conference call

 

 

 

When:

 

Tuesday, May 9, 2023, at 10:00 a.m. EST (7:00 a.m. PST)

 

 

 

Dial In Number:

 

To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 8054202.

 

 

 

Webcast:

 

To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.

 

 

 

Call Replay:

 

A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.

 

 

 

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
Investors@Stereotaxis.com